Edesa Biotech, Inc.
Clinical-stage biopharma developing therapies for inflammatory and immune diseases.
EDSA | US
Overview
Corporate Details
- ISIN(s):
- CA27966L1085 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 100 SPY COURT, 0 MARKHAM
- Website:
- https://www.edesabiotech.com/
- Sector:
- Manufacturing
Description
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for inflammatory and immune-related diseases. The company develops host-directed therapeutics as alternatives to conventional treatments like steroids and JAK inhibitors. Its clinical pipeline targets various conditions, including a significant program for Acute Respiratory Distress Syndrome (ARDS), which has demonstrated clinically significant improvements in survival and recovery. Edesa also develops therapies for dermatological and anorectal conditions, with the goal of addressing unmet medical needs in patients with acute and chronic diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Edesa Biotech, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Edesa Biotech, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Edesa Biotech, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
